Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1989 Mar;134(3):677–692.

Long-term effects of bone marrow transplantation in dogs with mucopolysaccharidosis I.

M A Breider 1, R M Shull 1, G Constantopoulos 1
PMCID: PMC1879520  PMID: 2493739

Abstract

The therapeutic effects of allogeneic bone marrow transplantation (BMT) in a canine model of mucopolysaccharidosis I (MPS I) were investigated. Long-term post-BMT pathologic and biochemical studies were performed on three groups of dogs: 1) MPS I-affected dogs that did not receive BMT, 2) MPS I-affected dogs that received total body irradiation followed by an allogeneic BMT, and 3) normal, unaffected dogs that served as BMT donors. All dogs were necropsied at approximately 20 months after BMT. The severity of MPS I-related lesions in the dogs receiving BMT was greatly diminished. These dogs had only slight cardiac valvular thickening, no meningeal thickening, no renal tubular epithelial vacuolation, decreased neuronal vacuolation, decreased corneal stromal vacuolation, and greatly diminished arterial medial thickening. The severity and incidence of degenerative arthropathy also were decreased in BMT dogs, however, vertebral lesions were similar to nontransplanted, affected dogs. Chondrocytes of both MPS I-BMT and MPS I-no BMT groups had similar marked cytoplasmic vacuolation, except for MPS I-BMT chondrocytes near the articular surface, which had more normal morphology. Ultrastructurally, the liver and kidney tissue in BMT recipients had no appreciable lysosomal accumulation of GAGs. These morphologic findings were supported by near normal levels and electrophoretic patterns of glycosaminoglycans (GAG) in most tissues of BMT recipient dogs. This study demonstrates that BMT is capable of substantially diminishing the severity of MPS I-related lesions in this canine model.

Full text

PDF
687

Images in this article

681Figure 1
on p.681
682Figure 2
on p.682
683Figure 3
on p.683
684Figure 4
on p.684
685Figure 5
on p.685
686Figure 6
on p.686
687Figure 7
on p.687
689Figure 8
on p.689
690Figure 9
on p.690

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blazar B. R., Whitley C. B., Desnick R. J., Pierpont M. E., Filipovich A. H., Ramsay N. K., Kersey J. H., Orr H. T., Yasmineh W. G., Tsai M. Y. Comparison of enzymatic activity with evidence of engraftment in patients with inborn errors of metabolism receiving allogeneic marrow transplantation. Birth Defects Orig Artic Ser. 1986;22(1):135–152. [PubMed] [Google Scholar]
  2. Boothe A. D., Weintroub H., Pentchev P. G., Jones J., Butler J., Barry J. E., Neumeyer B., Stivers J. A., Brady R. O. A lysosomal storage disorder in the BALB/c mouse: bone marrow transplantation. Vet Pathol. 1984 Jul;21(4):432–441. doi: 10.1177/030098588402100410. [DOI] [PubMed] [Google Scholar]
  3. Constantopoulos G., Dekaban A. S. Neurochemistry of the mucopolysaccharidoses: brain lipids and lysosomal enzymes in patients with four types of mucopolysaccharidosis and in normal controls. J Neurochem. 1978 May;30(5):965–973. doi: 10.1111/j.1471-4159.1978.tb12388.x. [DOI] [PubMed] [Google Scholar]
  4. Constantopoulos G., Shull R. M., Hastings N., Neufeld E. F. Neurochemical characterization of canine alpha-L-iduronidase deficiency disease (model of human mucopolysaccharidosis I). J Neurochem. 1985 Oct;45(4):1213–1217. doi: 10.1111/j.1471-4159.1985.tb05544.x. [DOI] [PubMed] [Google Scholar]
  5. Di Ferrante N., Nichols B. L., Donnelly P. V., Neri G., Hrgovcic R., Berglund R. K. Induced degradation of glycosaminoglycans in Hurler's and Hunter's syndromes by plasma infusion. Proc Natl Acad Sci U S A. 1971 Feb;68(2):303–307. doi: 10.1073/pnas.68.2.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gibbs D. A., Spellacy E., Tompkins R., Watts R. W., Mowbray J. F. A clinical trial of fibroblast transplantation for the treatment of mucopolysaccharidoses. J Inherit Metab Dis. 1983;6(2):62–81. doi: 10.1007/BF02338973. [DOI] [PubMed] [Google Scholar]
  7. Haskins M. E., Aguirre G. D., Jezyk P. F., Desnick R. J., Patterson D. F. The pathology of the feline model of mucopolysaccharidosis I. Am J Pathol. 1983 Jul;112(1):27–36. [PMC free article] [PubMed] [Google Scholar]
  8. Haskins M. E., McGrath J. T. Meningiomas in young cats with mucopolysaccharidosis I. J Neuropathol Exp Neurol. 1983 Nov;42(6):664–670. doi: 10.1097/00005072-198311000-00006. [DOI] [PubMed] [Google Scholar]
  9. Hata R., Nagai Y. A rapid and micro method for separation of acidic glycosaminoglycans by two-dimensional electrophoresis. Anal Biochem. 1972 Feb;45(2):462–468. doi: 10.1016/0003-2697(72)90208-4. [DOI] [PubMed] [Google Scholar]
  10. Kadota R. P., Smithson W. A. Bone marrow transplantation for diseases of childhood. Mayo Clin Proc. 1984 Mar;59(3):171–184. doi: 10.1016/s0025-6196(12)60770-8. [DOI] [PubMed] [Google Scholar]
  11. O'Reilly R. J., Brochstein J., Dinsmore R., Kirkpatrick D. Marrow transplantation for congenital disorders. Semin Hematol. 1984 Jul;21(3):188–221. [PubMed] [Google Scholar]
  12. Rattazzi M. C. Enzyme therapy in lysosomal storage diseases: current approaches. Prog Clin Biol Res. 1982;103(Pt B):573–587. [PubMed] [Google Scholar]
  13. Sakiyama T., Tsuda M., Owada M., Joh K., Miyawaki S., Kitagawa T. Bone marrow transplantation for Niemann-Pick mice. Biochem Biophys Res Commun. 1983 Jun 15;113(2):605–610. doi: 10.1016/0006-291x(83)91769-2. [DOI] [PubMed] [Google Scholar]
  14. Shull R. M., Breider M. A., Constantopoulos G. C. Long-term neurological effects of bone marrow transplantation in a canine lysosomal storage disease. Pediatr Res. 1988 Sep;24(3):347–352. doi: 10.1203/00006450-198809000-00015. [DOI] [PubMed] [Google Scholar]
  15. Shull R. M., Hastings N. E., Selcer R. R., Jones J. B., Smith J. R., Cullen W. C., Constantopoulos G. Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system. J Clin Invest. 1987 Feb;79(2):435–443. doi: 10.1172/JCI112830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Shull R. M., Helman R. G., Spellacy E., Constantopoulos G., Munger R. J., Neufeld E. F. Morphologic and biochemical studies of canine mucopolysaccharidosis I. Am J Pathol. 1984 Mar;114(3):487–495. [PMC free article] [PubMed] [Google Scholar]
  17. Shull R. M., Walker M. A. Radiographic findings in a canine model of mucopolysaccharidosis I. Changes associated with bone marrow transplantation. Invest Radiol. 1988 Feb;23(2):124–130. doi: 10.1097/00004424-198802000-00008. [DOI] [PubMed] [Google Scholar]
  18. Shull R. Impaired urea clearance in canine mucopolysaccharidosis I. Vet Clin Pathol. 1987;16(2):54–58. doi: 10.1111/j.1939-165x.1987.tb00465.x. [DOI] [PubMed] [Google Scholar]
  19. Slavin S., Yatziv S. Correction of enzyme deficiency in mice by allogeneic bone marrow transplantation with total lymphoid irradiation. Science. 1980 Dec 5;210(4474):1150–1152. doi: 10.1126/science.7003711. [DOI] [PubMed] [Google Scholar]
  20. Spellacy E., Shull R. M., Constantopoulos G., Neufeld E. F. A canine model of human alpha-L-iduronidase deficiency. Proc Natl Acad Sci U S A. 1983 Oct;80(19):6091–6095. doi: 10.1073/pnas.80.19.6091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Stefanovich V., Gore I. A micromethod for the determination of acid mucopolysaccharides in vascular tissue. J Chromatogr. 1967 Dec;31(2):473–478. doi: 10.1016/s0021-9673(01)86097-0. [DOI] [PubMed] [Google Scholar]
  22. Suzuki K., Hoogerbrugge P. M., Poorthuis B. J., Bekkum D. W., Suzuki K. The twitcher mouse. Central nervous system pathology after bone marrow transplantation. Lab Invest. 1988 Mar;58(3):302–309. [PubMed] [Google Scholar]
  23. Wassman E. R., Johnson K., Shapiro L. J., Itabashi H., Rimoin D. L. Postmortem findings in the Hurler-Scheie syndrome (mucopolysaccharidosis I-H/S). Birth Defects Orig Artic Ser. 1982;18(3B):13–18. [PubMed] [Google Scholar]
  24. Wenger D. A., Gasper P. W., Thrall M. A., Dial S. M., LeCouteur R. A., Hoover E. A. Bone marrow transplantation in the feline model of arylsulfatase B deficiency. Birth Defects Orig Artic Ser. 1986;22(1):177–186. [PubMed] [Google Scholar]
  25. Whitley C. B., Ramsay N. K., Kersey J. H., Krivit W. Bone marrow transplantation for Hurler syndrome: assessment of metabolic correction. Birth Defects Orig Artic Ser. 1986;22(1):7–24. [PubMed] [Google Scholar]
  26. Yeager A. M., Singer H. S., Buck J. R., Matalon R., Brennan S., O'Toole S. O., Moser H. W. A therapeutic trial of amniotic epithelial cell implantation in patients with lysosomal storage diseases. Am J Med Genet. 1985 Oct;22(2):347–355. doi: 10.1002/ajmg.1320220219. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES